EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Fueling early tumorigenesis: interplay between the exposome, obesity-driven metabolic dysfunction and early-onset colorectal and breast cancer

Mansi Upadhyay iD, Arianna V Bastian iD, Thomas D Cardaci iD, Minjeong Kim iD, Liza Makowski iD, Susan E Steck iD, E Angela Murphy iD

Carcinogenesis · 07.07.2026 · 47 (3)

DOI: 10.1093/carcin/bgag063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Carcinogenesis, online erschienen am 15.09.2026. Verfasst von Mansi Upadhyay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, United States. Hauptthemen laut MEDLINE: Obesity, Breast Neoplasms, Colorectal Neoplasms, Exposome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, Center for Clinical & Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early-onset cancers (EOCs), defined as cancers diagnosed before the age of 50, are increasing globally. This rise cannot be fully explained by improved detection, suggesting the involvement of evolving environmental and lifestyle-related risk factors. In parallel, the global prevalence of obesity has increased substantially, particularly among younger populations. Obesity is increasingly recognized not simply as excess adiposity, but as a systemic metabolic state characterized by insulin resistance, hyperinsulinemia, chronic low-grade inflammation, altered lipid metabolism, hormonal dysregulation, microbiome disruption, and epigenetic remodeling. These perturbations create a pro-tumorigenic environment that may promote early tumor initiation and progression. Importantly, when metabolic dysfunction arises during critical developmental windows, including in utero, childhood, adolescence, and early adulthood, it may establish long-lasting biological programs that influence growth signaling, immune function, and tissue homeostasis. In this context, increasing attention has shifted toward the “exposome,” defined as the totality of environmental exposures encountered across the lifespan and their interactions with biological susceptibility. These exposures may contribute to obesity-associated metabolic dysfunction and interact with one another to influence cancer risk, underscoring the multifactorial nature of EOC development. In this review, we integrate epidemiologic and mechanistic evidence linking obesity and metabolic dysfunction to EOCs, with a focus on colorectal and breast cancers. We highlight key biological pathways, including metabolic signaling, inflammation, microbiome alterations, endocrine disruption, and epigenetic reprogramming, and discuss emerging strategies for prevention and early risk stratification. Understanding the interplay between metabolic health and the exposome may provide critical insights into the prevention of EOCs in younger populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityBreast NeoplasmsColorectal NeoplasmsExposomeCarcinogenesisHumansFemaleAnimalsRisk FactorsDevelopmental Origins of Health and DiseaseAge of OnsetEpigenesis, Genetic

Stichwörter der Autor:innen

early life obesityearly-onset cancerexposomemetabolic dysregulationmetaflammation

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, United States.
  • Department of Health and Exercise Science, Colorado State University, Fort Collins, CO 80523, United States.
  • Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
  • University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
  • Department of Medicine, Division of Hematology and Oncology, University of Tennessee Health Science Center, Memphis, TN 38117, United States.
  • Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, United States.

ORCID-Profile: Mansi Upadhyay, Arianna V Bastian, Thomas D Cardaci, Minjeong Kim, Liza Makowski, Susan E Steck, E Angela Murphy

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • Center for Clinical & Translational Research
  • University of South Carolina
  • NCI NIH HHS
  • National Cancer Institute's Metabolic Dysregulation and Cancer Risk Program
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Upadhyay, M., Bastian, A. V., Cardaci, T. D., Kim, M., Makowski, L., Steck, S. E., & Murphy, E. A. (2026). Fueling early tumorigenesis: interplay between the exposome, obesity-driven metabolic dysfunction and early-onset colorectal and breast cancer. Carcinogenesis, 47(3). https://doi.org/10.1093/carcin/bgag063

Vancouver

Upadhyay M, Bastian AV, Cardaci TD, Kim M, Makowski L, Steck SE, et al. Fueling early tumorigenesis: interplay between the exposome, obesity-driven metabolic dysfunction and early-onset colorectal and breast cancer. Carcinogenesis. 2026;47(3). doi:10.1093/carcin/bgag063

BibTeX
@article{Upadhyay2026,
  author = {Upadhyay, Mansi and Bastian, Arianna V and Cardaci, Thomas D and Kim, Minjeong and Makowski, Liza and Steck, Susan E and Murphy, E Angela},
  title = {Fueling early tumorigenesis: interplay between the exposome, obesity-driven metabolic dysfunction and early-onset colorectal and breast cancer},
  journal = {Carcinogenesis},
  year = {2026},
  volume = {47},
  number = {3},
  doi = {10.1093/carcin/bgag063}
}
Kostenlos starten →